Skip to content
Recall Observatory FDA recall evidence

Drug product

Diltiazem Hydrochloride Extended-Release Capsules, USP 120mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-555-01.

D-0098-2025

November 01, 2024

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 95660
Status
Ongoing
Classification
Class II
Quantity
7296 bottles
Official record key
drug-enforcement:D-0098-2025

Official wording

Reason: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.

Code information: Lot #:17222547, Exp. Date, 11/30/2024; 17230598, Exp. Date 02/28/2025

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-nitroso-Desmethyl-Diltiazem impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations